APA (7th ed.) Citation

F, K., A, N., & TA, S. (2024). Talking to Your Patients About Psychedelics: Using an Informed Approach and Understanding Indications, Risks, and Benefits. The primary care companion for CNS disorders, 26(5), . https://doi.org/10.4088/PCC.24f03783

Chicago Style (17th ed.) Citation

F, King, Nahlawi A, and Stern TA. "Talking to Your Patients About Psychedelics: Using an Informed Approach and Understanding Indications, Risks, and Benefits." The Primary Care Companion for CNS Disorders 26, no. 5 (2024). https://doi.org/10.4088/PCC.24f03783.

MLA (9th ed.) Citation

F, King, et al. "Talking to Your Patients About Psychedelics: Using an Informed Approach and Understanding Indications, Risks, and Benefits." The Primary Care Companion for CNS Disorders, vol. 26, no. 5, 2024, https://doi.org/10.4088/PCC.24f03783.